Overview
Chemours Q3 2025 net sales flat yr/yr, driven by strong Opteon™ Refrigerants growth
Adjusted EPS and adj net income for Q3 2025 missed analyst expectations
Adjusted EBITDA for Q3 2025 beats analyst expectations
Outlook
Company expects Q4 2025 net sales to decrease 10-15% sequentially
Chemours forecasts Q4 2025 consolidated Adjusted EBITDA between $130 mln and $160 mln
TSS expects Q4 2025 sequential net sales to decrease high-teens to low-twenties percentage range
TT anticipates Q4 2025 sequential net sales to decrease high single-digits to low-teens percentage range
APM forecasts Q4 2025 sequential net sales to decrease low single-digit percentage range
Result Drivers
OPTEON™ REFRIGERANTS - Strong demand for Opteon™ Refrigerants drove growth in TSS segment, per CEO Denise Dignam
OPERATIONAL DISRUPTIONS - Resolved outage at Washington Works site impacted APM volumes, affecting overall sales
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
Meet
$1.5 bln
$1.5 bln (7 Analysts)
Q3 Adjusted EPS
Miss
$0.20
$0.25 (9 Analysts)
Q3 Adjusted Net Income
Miss
$30 mln
$37.84 mln (6 Analysts)
Q3 Adjusted EBITDA
Beat
$195 mln
$185.73 mln (7 Analysts)
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy", 4 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the diversified chemicals peer group is "buy."
Wall Street's median 12-month price target for Chemours Co is $17.00, about 29.1% above its November 5 closing price of $12.05
The stock recently traded at 6 times the next 12-month earnings vs. a P/E of 6 three months ago
Press Release: ID:nBwqpX1Na
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)